Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Shree Sharma

Concepts (117)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Renal Cell
2
2010
101
0.650
Why?
Kidney Neoplasms
2
2010
174
0.620
Why?
Glomerulonephritis, Membranous
3
2020
27
0.520
Why?
Diabetic Nephropathies
1
2013
63
0.420
Why?
Kidney
2
2013
686
0.380
Why?
Angiogenesis Inducing Agents
1
2010
8
0.360
Why?
Glomerulonephritis, IGA
1
2010
5
0.360
Why?
PAX2 Transcription Factor
1
2010
22
0.360
Why?
Podocytes
1
2010
19
0.360
Why?
Carcinoma, Papillary
1
2010
49
0.350
Why?
Neovascularization, Physiologic
1
2010
68
0.350
Why?
Proto-Oncogene Proteins B-raf
1
2010
78
0.340
Why?
Diabetes Mellitus
1
2013
284
0.340
Why?
Vascular Endothelial Growth Factor A
1
2010
183
0.320
Why?
Neovascularization, Pathologic
1
2010
153
0.310
Why?
Angiogenesis Inhibitors
1
2010
182
0.310
Why?
Heart Diseases
1
2010
212
0.300
Why?
Immunohistochemistry
1
2010
975
0.290
Why?
Colorectal Neoplasms
1
2010
256
0.280
Why?
Adenocarcinoma
1
2010
402
0.260
Why?
Kidney Diseases
2
2019
213
0.230
Why?
Lupus Nephritis
1
2020
17
0.180
Why?
Lupus Erythematosus, Systemic
1
2020
68
0.170
Why?
Biopsy
2
2013
592
0.170
Why?
Glomerulonephritis
1
2019
14
0.170
Why?
Humans
13
2020
50389
0.130
Why?
Proflavine
1
2015
1
0.120
Why?
Endothelin-1
1
2015
31
0.120
Why?
Fluorescent Dyes
1
2015
105
0.120
Why?
Point-of-Care Systems
1
2015
55
0.120
Why?
Phenazopyridine
1
2014
3
0.110
Why?
Nephritis, Interstitial
1
2014
9
0.110
Why?
Contrast Media
1
2015
190
0.110
Why?
Glomerular Filtration Rate
1
2013
114
0.110
Why?
Myocardium
1
2015
444
0.100
Why?
Vascular Endothelial Growth Factors
1
2010
13
0.090
Why?
Microscopy, Electron, Transmission
1
2010
75
0.090
Why?
Colonic Neoplasms
1
2012
158
0.090
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2010
11
0.090
Why?
Hematuria
1
2010
26
0.090
Why?
Proteinuria
1
2010
40
0.090
Why?
Fluorescent Antibody Technique
1
2010
112
0.090
Why?
Fibroblast Growth Factors
1
2010
45
0.090
Why?
Neoplasms
1
2020
1237
0.090
Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2010
8
0.090
Why?
Patents as Topic
1
2010
9
0.090
Why?
Gene Expression Regulation
1
2015
964
0.090
Why?
Female
5
2019
26981
0.090
Why?
DNA Mutational Analysis
1
2010
176
0.090
Why?
Integrins
1
2010
30
0.090
Why?
Cell Nucleus
1
2010
186
0.090
Why?
DNA, Neoplasm
1
2010
146
0.080
Why?
Neoplasm Metastasis
1
2010
235
0.080
Why?
Matrix Metalloproteinases
1
2010
47
0.080
Why?
Aging
1
2015
675
0.080
Why?
Amlodipine
1
2009
14
0.080
Why?
Renal Insufficiency
1
2010
108
0.080
Why?
Genetic Therapy
1
2010
118
0.080
Why?
Fluorobenzenes
1
2009
21
0.080
Why?
Cardiomegaly
1
2009
39
0.080
Why?
TOR Serine-Threonine Kinases
1
2010
77
0.080
Why?
Stem Cell Transplantation
1
2010
179
0.080
Why?
Hypercholesterolemia
1
2009
37
0.080
Why?
Immunoglobulin G
2
2020
185
0.080
Why?
Calcium Channel Blockers
1
2009
64
0.080
Why?
Intracellular Signaling Peptides and Proteins
1
2010
139
0.080
Why?
Male
6
2020
25718
0.080
Why?
Sulfonamides
1
2009
125
0.080
Why?
Sensitivity and Specificity
1
2010
875
0.080
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2009
137
0.080
Why?
Pyrimidines
1
2009
193
0.080
Why?
Drug Delivery Systems
1
2010
143
0.070
Why?
Nanoparticles
1
2010
152
0.070
Why?
Predictive Value of Tests
1
2010
934
0.070
Why?
Diagnosis, Differential
1
2010
1042
0.070
Why?
Aged
3
2020
9590
0.070
Why?
Models, Biological
1
2010
723
0.070
Why?
Antibodies, Monoclonal
1
2010
462
0.060
Why?
Retrospective Studies
1
2013
6223
0.050
Why?
Middle Aged
2
2013
12460
0.050
Why?
Neural Cell Adhesion Molecules
1
2020
9
0.050
Why?
Thrombospondins
1
2020
8
0.040
Why?
Receptors, Phospholipase A2
1
2020
14
0.040
Why?
Calcium-Binding Proteins
1
2020
55
0.040
Why?
Autoantigens
1
2020
50
0.040
Why?
Autoantibodies
1
2020
114
0.040
Why?
Kidney Glomerulus
1
2019
39
0.040
Why?
Multiple Myeloma
1
2012
2949
0.040
Why?
Aspartic Acid Endopeptidases
1
2015
16
0.030
Why?
beta-Galactosidase
1
2015
35
0.030
Why?
Gene Knockdown Techniques
1
2015
106
0.030
Why?
Metalloendopeptidases
1
2015
69
0.030
Why?
Microscopy, Fluorescence
1
2015
164
0.030
Why?
Estrogen Receptor alpha
1
2015
86
0.030
Why?
Enzyme Activation
1
2015
272
0.030
Why?
RNA Interference
1
2015
178
0.030
Why?
Fibrosis
1
2015
179
0.030
Why?
Up-Regulation
1
2015
449
0.030
Why?
Fibroblasts
1
2015
354
0.030
Why?
Mice
2
2015
5688
0.020
Why?
Fatal Outcome
1
2012
195
0.020
Why?
Cell Line, Tumor
1
2015
1399
0.020
Why?
Cholesterol, Dietary
1
2009
19
0.020
Why?
Receptors, LDL
1
2009
67
0.020
Why?
Lipids
1
2009
149
0.020
Why?
Drug Therapy, Combination
1
2009
383
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
578
0.020
Why?
Signal Transduction
1
2015
1625
0.020
Why?
Body Weight
1
2009
514
0.020
Why?
Animals
2
2015
13173
0.020
Why?
Hematopoietic Stem Cell Transplantation
1
2012
555
0.020
Why?
Gene Expression
1
2009
613
0.020
Why?
Blood Pressure
1
2009
529
0.020
Why?
Mice, Knockout
1
2009
840
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2012
1003
0.020
Why?
Disease Models, Animal
1
2009
1419
0.010
Why?
Treatment Outcome
1
2009
5230
0.010
Why?
Sharma's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description